我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

男性冠心病患者介入治疗前后外周血平滑肌前体细胞数量的变化(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第3期
页码:
347-350
栏目:
临床研究
出版日期:
2011-05-12

文章信息/Info

Title:
Changes of circulating smooth muscle progenitor cells in male patients with coronary heart disease before and after percutaneous coronary intervention
作者:
倪旭东周学凯李飞张荣庆郭文怡
第四军医大学西京医院心脏内科,陕西 西安 710032
Author(s):
NI Xu-dong ZHOU Xue-kai LI Fei ZHANG Rong-qing GUO Wen-yi
Department of Cardiovascular Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China
关键词:
干细胞冠状动脉疾病冠状动脉血管成形术经腔经皮平滑肌前体细胞
Keywords:
stem cells coronary disease coronary angioplasty transluminal percutaneous smooth muscle progenitor cells
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:观察比较正常人与冠心病患者外周血平滑肌前体细胞(SPCs)数量的差异,以及冠心病患者在经皮冠脉介入治疗(PCI)前后外周血中SPCs数量的变化。方法: 将研究对象分为3组:稳定型心绞痛(SAP)组、不稳定型心绞痛(UAP)及正常对照组(NC)。SPCs以CD14和CD105双阳性确定,利用流式细胞仪双色分析技术筛选各组在PCI术前、术后即刻、术后72 h SPCs占外周血有核细胞的百分比。结果: PCI术前,外周血中SPCs数量在SAP组为(0.20±0.13)%、UAP组为(0.28±0.18)%,均明显高于NC组[(0.12±0.10)%](均P<0.01),UAP组外周血中SPCs数量明显高于SAP组(P<0.01)。UAP组外周血中SPCs的数量在PCI术后72 h较术前明显增加[(0.34±0.25)% vs. (0.28±0.18)%,P<0.01]。结论: 外周血中SPCs数量的变化及PCI对外周血SPCs数量的影响可能与冠心病的临床类型有关。
Abstract:
AIM:To compare the number of circulating smooth muscle progenitor cells (SPCs) between normal controls and patients with coronary heart disease (CHD) and to explore the influence of percutaneous coronary (PCI) on the SPC number in CHD patients. METHODS: A total of 33 hospitalized male CHD patients were enrolled and divided into three groups, including stable angina pectoris (SAP) group and unstable angina pectoris (UA) group. Patients with normal coronary angiography served as controls. The percentage of SPCs in peripheral blood mononuclear cells (PBMCs) was measured at admission and 72 h after PCI in CHD patients by double-color flow cytometry analysis. SPCs were identified with CD14+/CD105+. RESULTS: At admission, the percentage of SPCs in PBMCs was significantly higher in SAP group (0.20±0.13)% and UA group (0.28±0.18)% than in control group [(0.12±0.10)%, all P<0.01]. The number of SPCs in UA group was significantly higher than in the SAP group (P<0.01). In the UA group, the number of SPCs at 72 h after PCI (0.34±0.25)% was significantly higher than before operation [(0.28±0.18)%, P<0.01] and tended to be higher than the value immediately after PCI. CONCLUSION: Stent implantation may induce the mobilization of bone marrow-derived smooth muscle progenitor cells. The number of peripheral SPCs in CHD patients is lower than in normal subjects and is negatively related with the severity of coronary heart disease. The number of circulating SPCs increases post-PCI in patients with UA.

参考文献/References

[1]Sata M,Saiura A,Nagai R,et al.Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis[J].NatMed,2002,8(4):403-409.
[2] Sugiyama S,Kugiyama K,Nakamura S,et al.Characterization of smmoth muscle-like cells in circulating human peripheralblood[J].Atherosclerosis,2006,187(2):351-362.
[3]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛的诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206.
[4]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-25.
[6]Iwakura A,Luedemann C,Shastry S,et al.Estrogen-mediated,endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury[J].Circulation,2003,108(25):3115-3121.
[7]Lowe HC,Oesterle SN,Khaehigian LM.Coronary in-stent restenosis:current status and future strategies[J].J Am Coll Cardiol,2002,39(2):183-193.
[8]李庆,汪渊.血管祖细胞与动脉粥样硬化[J].中华心血管病杂志,2008,36(12):1134-1137.
[9]Simper D,Stalboerger PG,Caplice NM,et al.Smooth muscle progenitor cells in human blood[J].Circulation,2002,106(10):1199-1204.
[10]Hu Y,Zhang Z,Xu Q,et al.Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice[J].J Clin Invest,2004,113(9):1258-1265.
[11] Beltrami AP,Barlucchi L,Torella D,et al.Adult cardiac stem cells are multipotentand support myocardial regeneration[J]. Cell,2003,114(6):763-776.
[12]Majka SM,Jackson KA,Kienstra KA,et al.Distinct progenitor populations in muscle are bone marrow derived and exhibit different cell fates during vascular regeneration[J].J Clin Invest,2003,111(1):71-79.
[13]Schober A,Hoffmann R,Oprée N,et al.Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease[J].Am J Cardiol,2005,96(8):1116-1122.
[14]Yeh ET,Zhang S,Wu HD,et al. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo[J].Circulation,2003,108(17):2070-2073.
[15]Xu Q.The impact of progenitor cells in atherosclerosis[J].Nat Clin Pract Cardiovasc Med,2006,3(2):94-101.

备注/Memo

备注/Memo:
收稿日期:2010-06-08.通讯作者:郭文怡,主任医师,主要从事冠心病介入治疗研究Email:wenyiguo@yahoo.com 作者简介:倪旭东,主治医师,硕士生Email:dzn229@163.com
更新日期/Last Update: 2011-03-17